YK-46
y-k-forty-six
Category
Compound type
Phase / Status
Extremely limited research. Not well characterized for safety or efficacy.
Standard Dose
Unknown
Half-life
Plasma elimination
Route(s)
Oral
Research Stage
Animal/in-vitro data only; no human trial evidence.
Overview
YK-46 is an extremely under-studied compound. It is sometimes described as combining androgen receptor activity with potential myostatin-related effects, but there is very little public human or clinical data. Treat it as highly experimental.
Plain-language summary
YK-46 is an extremely under-studied compound. It is sometimes described as combining androgen receptor activity with potential myostatin-related effects, but there is very little public human or clinical data. Treat it as highly experimental.
Administration Routes
- Oral
Also known as
Mechanisms
SARM/Steroid hybrid concept - proposed to bind androgen receptors and may influence myostatin signaling. The actual biological effects in humans are not well established.
Detailed mechanism
SARM/Steroid hybrid concept - proposed to bind androgen receptors and may influence myostatin-related pathways. Intended selectivity is described, but human data is not established.
Safety
Side effects
- Unknown - insufficient data to define side effects
- Potential testosterone suppression (based on androgen-receptor activity)
- Potential liver risk has been raised but is not well characterized
Reported benefits
- Potential muscle-building effects (theoretical)
- Possible myostatin-related effects (theoretical)
- No reliable safety or efficacy profile established
Safety profile
Limited human safety data and substantial uncertainty. Avoid self-experimentation; seek professional guidance if considering any use.
Clinical trials
Preclinical studies in limited models; human trials are not well established.
Structure
Verified structure
YK-46
No public sequence, formula, or exact registry structure is available for this record.
No trustworthy illustration yet
This entry is missing a public exact structure, sequence, or usable formula. The verification record is still stored so it remains visible in the audit trail.
- Chemical Formula
- Not publicly available
- Molecular Weight
- Not publicly available
- CAS Number
- Not publicly available
Stack Context
No stack data available.
References
- 1View source
Selective androgen receptor modulator YK11 regulates myogenic differentiation through follistatin (Biol Pharm Bull)
2013
- 2View source
Selective androgen receptor modulators as function promoting therapies
2009
- 3View source
Regulation of muscle mass by myostatin (Annual Review of Cell and Developmental Biology)
2004
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.